Study guide
Myopathy, CPEO and Kearns–Sayre syndrome
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Myopathy, CPEO and Kearns–Sayre syndrome
Key Takeaways Explain This Topic AI
Myopathic motility loss can be progressive and relatively symmetric without the variability of myasthenia.
CPEO and related mitochondrial disease require assessment of systemic features and genetic context.
Kearns–Sayre presentations with conduction disease need urgent cardiac assessment and selected pacing, not a universal prophylactic rule.
Last updated: October 2026
Ocular Myopathies & Mitochondrial Disorders
When progressive ptosis and ophthalmoplegia develop symmetrically without diurnal fluctuation, pupillary involvement, or pain, primary mitochondrial and muscular dystrophies must be investigated.
Chronic Progressive External Ophthalmoplegia (CPEO)
CPEO is the most common mitochondrial myopathy affecting the visual system:
Genetics: Most commonly caused by sporadic, single large-scale deletions of mitochondrial DNA (mtDNA) , such as the common 4,977-base-pair deletion. Autosomal dominant and recessive familial forms occur secondary to mutations in nuclear genes controlling mtDNA replication (e.g. POLG , TWNK , SLC25A4 ).
Clinical Presentation: Insidious, slowly progressive, symmetrical bilateral ptosis , followed years later by symmetrical limitation of ocular ductions in all directions of gaze .
The Diplopia Paradox: Despite near-complete external ophthalmoplegia (the eyes may become completely fixed in primary position), patients rarely complain of diplopia . Because the myopathic process progresses in a remarkably symmetrical fashion between both orbits, alignment remains parallel.
Diagnostic Hallmarks: Normal pupils and normal accommodation; accompanying severe orbicularis oculi weakness ; negative myasthenic serology; modified Gomori trichrome staining of skeletal muscle biopsy demonstrates ragged-red fibers (subsarcolemmal accumulations of structurally abnormal mitochondria) and cytochrome c oxidase (COX)-negative fibers .
Kearns-Sayre Syndrome (KSS)
Kearns-Sayre syndrome is a severe, multisystem mitochondrial deletion syndrome defined by a strict clinical triad:
- Onset before age 20 years;
- Chronic Progressive External Ophthalmoplegia (CPEO);
Atypical Pigmentary Retinopathy: Bilateral, diffuse, fine 'salt-and-pepper' retinal pigment epithelium atrophy and pigment clumping, characteristically involving the macula and mid-periphery. Unlike classical retinitis pigmentosa, arteriolar attenuation and waxy disc pallor are absent, and electroretinography (ERG) demonstrates only mild or diffuse photoreceptor dysfunction.
In addition to the triad, diagnosis requires at least one of the following systemic manifestations:
Cardiac conduction disease : KSS requires cardiac assessment and surveillance because conduction failure can be life-threatening. Pacing is selected by established disease and specialist risk, not automatically in every patient at diagnosis.
Cerebrospinal Fluid (CSF) Protein > 100 mg/dL >100\text{ mg/dL} > 100 mg/dL ( > 1.0 g/L >1.0\text{ g/L} > 1.0 g/L );
Cerebellar Ataxia.
Oculopharyngeal Muscular Dystrophy (OPMD)
OPMD is an autosomal dominant, late-onset muscular dystrophy characterized by distinct genetic and clinical features:
Genetics: Caused by an expanded (GCN)11-18 trinucleotide repeat expansion in the PABPN1 gene (polyadenylate-binding protein nuclear 1) on chromosome 14q11.
Clinical Presentation: Characteristically manifests in the fifth or sixth decade (age 50 to 60 years) with progressive, symmetrical bilateral ptosis and severe, progressive dysphagia (pharyngeal muscle involvement). Patients suffer from choking episodes, nasal regurgitation, severe aspiration pneumonia, and cachexia.
Ophthalmoplegia: Limitation of ocular motility occurs late in the disease course and is milder than in CPEO.
Muscle Biopsy: characteristic intranuclear filamentous inclusions measuring 8.5 nm in diameter on electron microscopy and rimmed vacuoles on light microscopy.
Master Summary: Neuromuscular & Myopathic Motility Disorders
The following master table synthesizes the immunological, genetic, clinical, and histopathological criteria distinguishing these disorders:
Disorder Pathophysiology / Genetics Clinical Hallmarks Pupil Status Diagnostic Gold Standard Crucial Systemic Risk / Therapy
Ocular Myasthenia Gravis Autoimmune postsynaptic transmission disorder; antibody assays may be negative Fluctuating ptosis and variable diplopia Usually preserved Antibodies and specialist electrophysiology; SFEMG performance varies Pyridostigmine and selected immunotherapy; assess thymus and generalisation
MuSK Myasthenia Gravis Antibodies to muscle-specific kinase Often prominent bulbar, facial or neck weakness; ocular signs can occur Usually preserved Anti-MuSK assay and clinical/electrophysiological evidence Specialist immunotherapy; rituximab is an important option, particularly with inadequate initial response
Chronic Progressive External Ophthalmoplegia (CPEO) Sporadic mtDNA single deletions; nuclear POLG mutations Symmetrical painless ptosis and total ophthalmoplegia; no diplopia Normal Skeletal muscle biopsy: ragged-red fibers, COX-negative Ptosis crutches or frontalis suspension; genetic counseling
Kearns-Sayre Syndrome (KSS) Large-scale single mtDNA deletions (4.9 kb deletion) Triad: Onset < 20 y <20\text{y} < 20 y , CPEO, 'salt-and-pepper' retinopathy Normal mtDNA analysis; CSF protein > 100 mg/dL >100\text{ mg/dL} > 100 mg/dL Cardiac conduction assessment; pacing according to disease and specialist risk assessment
Oculopharyngeal Muscular Dystrophy (OPMD) Autosomal dominant PABPN1 GCN repeat expansion Onset 50-60y, bilateral ptosis, severe dysphagia , mild ophthalmoplegia Normal Genetic testing; muscle biopsy: intranuclear inclusions Aspiration pneumonia risk; cricopharyngeal myotomy
Test and Treatment Limits
Ice and enhanced-ptosis signs support MG but are not individually definitive. Protect the skin during ice testing. Antibody sensitivity differs in ocular and generalised disease. Single-fibre EMG depends on muscle, presentation and technique; a normal study is less reassuring in isolated diplopia than in typical ptosis, and abnormal jitter is not exclusive to MG. Review medicines that may worsen weakness, and assess breathing, swallowing and voice change urgently.
Thymoma assessment is relevant, but the MGTX thymectomy evidence was for selected generalised AChR-positive disease, not every ocular or MuSK presentation. Immunotherapy is selected by neurological severity and risks; rituximab can be an option in appropriate MuSK/generalised disease rather than an automatic response to one test. CPEO may produce diplopia and Kearns–Sayre requires cardiac surveillance, with pacing according to conduction disease and specialist risk. Oculopharyngeal dystrophy can be established genetically; biopsy is not compulsory in every case.